Citation: R. Ouseph et al., LYMPHOPROLIFERATIVE DISEASE SEEN AS A CARDIAC MASS AFTER ORTHOTOPIC HEART-TRANSPLANTATION, Journal of the American Society of Echocardiography, 11(7), 1998, pp. 758-760
Citation: R. Ouseph et al., CONTINUOUS VENOVENOUS HEMOFILTRATION AND HEMODIALYSIS AFTER ORTHOTOPIC HEART-TRANSPLANTATION, American journal of kidney diseases, 32(2), 1998, pp. 290-294
Citation: Km. Erbeck et al., RELATIONSHIP OF BONE DENSITOMETRY TO HYPERPARATHYROIDISM IN HEMODIALYSIS-PATIENTS, Journal of investigative medicine, 44(7), 1996, pp. 358-358
Citation: Km. Erbeck et al., BONE DENSITOMETRY DOES NOT PREDICT HYPERPARATHYROIDISM IN HEMODIALYSIS-PATIENTS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 2713-2713
Authors:
ERBECK KM
JACOBS AA
SMITH BA
BRIER ME
STEVENS DA
Citation: Km. Erbeck et al., RENAL REPLACEMENT THERAPY IN ALLOGENEIC VERSUS AUTOLOGOUS BONE-MARROWTRANSPLANTATION, Journal of the American Society of Nephrology, 6(3), 1995, pp. 462-462
Citation: Km. Erbeck et al., EFFECT OF HEMODIALYSIS ACCESS ON DELIVERED DOSE OF DIALYSIS (KT V)/, Journal of the American Society of Nephrology, 6(3), 1995, pp. 487-487
Citation: Aa. Jacobs et al., AN ALGORITHM-BASED PROTOCOL TO MANAGE IRON-DEFICIENCY AND ANEMIA IN ESRD, Journal of the American Society of Nephrology, 6(3), 1995, pp. 538-538
Authors:
WARD RA
BRIER ME
DEOREO P
ERBECK KM
HAMBURGER RJ
SMITH BA
Citation: Ra. Ward et al., PREDICTORS OF SHORT-TERM MORTALITY IN DIABETIC HEMODIALYSIS-PATIENTS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 567-567
Citation: Me. Brier et al., PREDICTING DOSE OF DIALYSIS USING AN ARTIFICIAL NEURAL-NETWORK - NETWORK-9 ADEQUACY STUDY, Journal of the American Society of Nephrology, 5(3), 1994, pp. 510-510